作为脊椎间盘退化治疗点的PTPN22:通过PI3K/AKT/mTOR轴调节线粒细胞衰变和热
Haibo Liang1, Shu Yang1, Yeheng Huang1
1Division of Spine Surgery, Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; School of the Second Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China.
Journal of advanced research
|May 11, 2025
概括
蛋白质氨酸酸酶非受体类型22 (PTPN22) 缺乏缓解椎间盘退化 (IDD) 通过增强细胞和减少细胞烧灭和细胞外矩阵降解. 这项研究确定PTPN22是IDD进展的关键因素,也是潜在的治疗点.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 椎间盘退化 (IDD) 是腰部疼痛 (LBP) 的主要原因,但其潜在机制尚未完全理解.
- 蛋白氨酸酸酶非受体类型22 (PTPN22) 与炎症性疾病有关,但其在IDD中的作用尚不清楚.
研究的目的:
- 研究PTPN22在椎间盘退化进展中的作用和分子机制.
- 评估在IDD中准PTPN22的治疗潜力.
主要方法:
- 分析了人体和老鼠核脉 (NP) 细胞中的PTPN22表达.
- 评估PTPN22敲击后的热,ECM降解,线粒体和线粒体功能.
- 研究了PI3K/AKT/mTOR通路和自.
- 在大鼠IDD模型中评估了PTPN22的淘汰效应.
主要成果:
- 在退行性NP细胞中,PTPN22表达被上调.
- 缺乏PTPN22增强了线粒体,改善了线粒体功能,并减少了NP细胞热和ECM降解.
- 抑制PI3K/AKT/mTOR通路调解了PTPN22缺乏的保护作用.
- 在体内,PTPN22敲击显著抑制了IDD进展.
结论:
- PTPN22 Knockdown 通过增强线粒细胞和减少热和 ECM 降解来改善 IDD.
- PTPN22是IDD病变的关键因素,也是治疗腰部疼痛的有前途的治疗标.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
The Intrinsic Apoptotic Pathway
5.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.6K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Translocation of Proteins into the Mitochondria
3.0K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.0K
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K


